Pascal Hickey has over 25 years’ international experience in drug development. He has held management responsibilities across various R&D functions in innovative and rapidly growing biotechnology companies, and has over 15 years' experience in allergy. Prior to joining Aravax, Dr Hickey was Vice President Early Development at Circassia Pharmaceuticals (UK).  

Dr Hickey received his Bachelor of Pharmacy from the Victorian College of Pharmacy and PhD from Monash University, Australia.